Terms: = Skin cancer AND MAF, MGC71685, 4094, ENSG00000178573
28 results:
1. Divergent molecular networks program functionally distinct CD8
Park SL; Christo SN; Wells AC; Gandolfo LC; Zaid A; Alexandre YO; Burn TN; Schröder J; Collins N; Han SJ; Guillaume SM; Evrard M; Castellucci C; Davies B; Osman M; Obers A; McDonald KM; Wang H; Mueller SN; Kannourakis G; Berzins SP; Mielke LA; Carbone FR; Kallies A; Speed TP; Belkaid Y; Mackay LK
Science; 2023 Dec; 382(6674):1073-1079. PubMed ID: 38033053
[TBL] [Abstract] [Full Text] [Related]
2. The clinicopathological impact of tumor-associated macrophages in patients with cutaneous malignant melanoma.
Asai Y; Yanagawa N; Osakabe M; Yamada N; Sugimoto R; Sato A; Ito K; Koike Y; Tanji T; Sakuraba M; Sato T; Sugai T
J Surg Oncol; 2024 Feb; 129(2):381-391. PubMed ID: 37916518
[TBL] [Abstract] [Full Text] [Related]
3. Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale: a systematic analysis of the global burden of disease study from 1990 to 2019.
Liu M; Wu M; Liu X; Zhou J; Lan Y; Zhang H; Zhang X; Leng L; Zheng H; Li J
Arch Dermatol Res; 2023 Dec; 315(10):2893-2904. PubMed ID: 37773351
[TBL] [Abstract] [Full Text] [Related]
4. Development of a Macrophage-Related Risk Model for Metastatic Melanoma.
Li Z; Zhang X; Jin Q; Zhang Q; Yue Q; Fujimoto M; Jin G
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762054
[TBL] [Abstract] [Full Text] [Related]
5. Targeting Melanoma-Associated Fibroblasts (mafs) with Activated γδ (Vδ2) T Cells: An In Vitro Cytotoxicity Model.
Hajdara A; Çakır U; Érsek B; Silló P; Széky B; Barna G; Faqi S; Gyöngy M; Kárpáti S; Németh K; Mayer B
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629075
[TBL] [Abstract] [Full Text] [Related]
6. Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor.
Mattila KE; Mäkelä S; Kytölä S; Andersson E; Vihinen P; Ramadan S; Skyttä T; Tiainen L; Vuoristo MS; Tyynelä-Korhonen K; Koivunen J; Kohtamäki L; Aittomäki K; Hernberg M
Acta Oncol; 2022 Oct; 61(10):1263-1267. PubMed ID: 36307938
[TBL] [Abstract] [Full Text] [Related]
7. Encorafenib plus cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: real-life data from an Italian multicenter experience.
Boccaccino A; Borelli B; Intini R; Antista M; Bensi M; Rossini D; Passardi A; Tamberi S; Giampieri R; Antonuzzo L; Noto L; Roviello G; Zichi C; Salati M; Puccini A; Noto C; Parisi A; Rihawi K; Persano M; Crespi V; Libertini M; Giordano M; Moretto R; Lonardi S; Cremolini C
ESMO Open; 2022 Jun; 7(3):100506. PubMed ID: 35696748
[TBL] [Abstract] [Full Text] [Related]
8. Immune Checkpoints Inhibitors and SRS/SBRT Synergy in Metastatic Non-Small-Cell Lung cancer and Melanoma: A Systematic Review.
Rodríguez Plá M; Dualde Beltrán D; Ferrer Albiach E
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769050
[No Abstract] [Full Text] [Related]
9. Longitudinal Relationship between Idylla Plasma ctBRAF V600 Mutation Detection and Tumor Burden in Patients with Metastatic Melanoma.
Linder MW; Egger ME; Van Meter T; Rai SN; Valdes R; Hall MB; Wu X; Alghamdi N; Chesney JA
Mol Diagn Ther; 2021 May; 25(3):361-371. PubMed ID: 33970440
[TBL] [Abstract] [Full Text] [Related]
10. Converting melanoma-associated fibroblasts into a tumor-suppressive phenotype by increasing intracellular Notch1 pathway activity.
Shao H; Moller M; Cai L; Prokupets R; Yang C; Costa C; Yu K; Le N; Liu ZJ
PLoS One; 2021; 16(3):e0248260. PubMed ID: 33705467
[TBL] [Abstract] [Full Text] [Related]
11. Ethnicity as modifier of risk for Vitamin D receptors polymorphisms: Comprehensive meta-analysis of all cancer sites.
Gnagnarella P; Raimondi S; Aristarco V; Johansson H; Bellerba F; Corso F; De Angelis SP; Belloni P; Caini S; Gandini S
Crit Rev Oncol Hematol; 2021 Feb; 158():103202. PubMed ID: 33387627
[TBL] [Abstract] [Full Text] [Related]
12. TOF-SIMS imaging reveals tumor heterogeneity and inflammatory response markers in the microenvironment of basal cell carcinoma.
Dimovska Nilsson K; Neittaanmäki N; Zaar O; Angerer TB; Paoli J; Fletcher JS
Biointerphases; 2020 Aug; 15(4):041012. PubMed ID: 32859133
[TBL] [Abstract] [Full Text] [Related]
13. Melanoma-associated fibroblasts impair CD8+ T cell function and modify expression of immune checkpoint regulators via increased arginase activity.
Érsek B; Silló P; Cakir U; Molnár V; Bencsik A; Mayer B; Mezey E; Kárpáti S; Pós Z; Németh K
Cell Mol Life Sci; 2021 Jan; 78(2):661-673. PubMed ID: 32328671
[TBL] [Abstract] [Full Text] [Related]
14. cancer genes mutation profiling in calcifying epithelial odontogenic tumour.
de Sousa SF; Diniz MG; França JA; Fontes Pereira TDS; Moreira RG; Santos JND; Gomez RS; Gomes CC
J Clin Pathol; 2018 Mar; 71(3):279-283. PubMed ID: 29127140
[TBL] [Abstract] [Full Text] [Related]
15. Transcription Factor mafB Promotes Hepatocellular Carcinoma Cell Proliferation through Up-Regulation of Cyclin D1.
Yu H; Jiang HL; Xu D; Jin JZ; Zhao ZM; Ma YD; Liang J
Cell Physiol Biochem; 2016; 39(2):700-8. PubMed ID: 27448450
[TBL] [Abstract] [Full Text] [Related]
16. Common BRAF(V600E)-directed pathway mediates widespread epigenetic silencing in colorectal cancer and melanoma.
Fang M; Hutchinson L; Deng A; Green MR
Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1250-5. PubMed ID: 26787892
[TBL] [Abstract] [Full Text] [Related]
17. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract] [Full Text] [Related]
18. Monitoring the process of pulmonary melanoma metastasis using large area and label-free nonlinear optical microscopy.
Hua D; Qi S; Li H; Zhang Z; Fu L
J Biomed Opt; 2012 Jun; 17(6):066002. PubMed ID: 22734758
[TBL] [Abstract] [Full Text] [Related]
19. Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents.
Usmani SZ; Heuck C; Mitchell A; Szymonifka J; Nair B; Hoering A; Alsayed Y; Waheed S; Haider S; Restrepo A; Van Rhee F; Crowley J; Barlogie B
Haematologica; 2012 Nov; 97(11):1761-7. PubMed ID: 22689675
[TBL] [Abstract] [Full Text] [Related]
20. Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control study.
Piranda DN; Festa-Vasconcellos JS; Amaral LM; Bergmann A; Vianna-Jorge R
BMC Cancer; 2010 Nov; 10():613. PubMed ID: 21059239
[TBL] [Abstract] [Full Text] [Related]
[Next]
